TransGen Biotech
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A precision medicine company developing integrated diagnostic and therapeutic biologics platforms.
OncologyInfectious DiseaseGenetic Disorders
Technology Platform
Integrated genomics and biologics platform combining NGS-based diagnostics with recombinant protein therapeutic development.
Opportunities
Capitalizing on China's substantial investment in precision medicine and genomic infrastructure.
Risk Factors
Regulatory complexity in simultaneously advancing diagnostic and therapeutic regulated products.
Competitive Landscape
Faces competition from global giants like Illumina in diagnostics and domestic biopharma firms in biologics, but its integrated model is a differentiator.